智通财经APP讯，领航医药生物科技(00399)发布公告，于2025年7月15日，本公司与认购人A张彪兵订 立认购协议A，认购人A有条件同意认购而本公司有条件同意配发及发行合共6000万股股份，认购价A 为每股认购股份A 0.312港元。认购股份A将根据一般授权配发及发行。 认购价A和认购价B较股份于2025年7月15日(即认购协议A日期)在联交所所报的收市价每股0.39港元折 让约20%。 该等认购事项所得款项总额及所得款项净额将分别为约2808万港元及2778万港元，拟用作本集团的一般 营运资金。 董事认为，考虑到近期市况对本集团而言是巩固其资本基础及财务状况的良机，透过发行认购股份筹集 资金属合理。董事认为，发行认购股份是筹集额外资金的适当途径，因为该等认购价较上文所载市价有 所折让，而此乃经本公司分别与该等认购人公平磋商后达致。 假设本公司已发行股本于本公告日期至完成期间并无变动，认购股份A占于本公告日期本公司现有全部 已发行股本约3.00%;及本公司经发行认购股份扩大后全部已发行股本约2.92%。 于2025年7月15日，本公司与认购人B陈静订立认购协议B，认购人B有条件同意认购而本公司有条件同 意 ...

证券代码：002044 证券简称：美年健康 公告编号：2025-040 美年大健康产业控股股份有限公司 关于实施 2024 年年度分红派息后发行股份购买资产暨关联交易 所涉发行股份购买资产的股份发行价格调整的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 因实施 2024 年年度分红派息，美年大健康产业控股股份有限公司（以下简 称"公司"）发行股份购买资产暨关联交易事项的股份发行价格将由 4.74 元/股调 整为 4.73 元/股。 本次交易中购买资产所涉及股份发行价格的定价基准日为公司第九届董事 会第七次（临时）会议决议公告之日，经交易各方友好协商，公司确定本次交易 的股份发行价格为 4.74 元/股，不低于定价基准日前 120 个交易日公司股票交易 均价的 80%。 在本次交易的定价基准日至发行日期间，上市公司如有派息、送股、资本 公积转增股本等除权、除息事项，发行价格将按下述公式进行调整，计算结果 向上进位并精确至分。发行价格的调整公式如下： 派发股票红利或资本公积转增股本：P1=P0/(1+n)； 配股：P1=(P0+A×k)/( ...

General Provisions - The Articles of Association are established to safeguard the legitimate rights and interests of the Company, its shareholders, employees, and creditors, and to regulate the organization and activities of the Company [1][3] - The Company is a joint-stock limited company incorporated under relevant laws and regulations in China [2][3] - The registered capital of the Company is RMB 1,785,399,930 [5][6] Business Objectives and Scope - The Company's business objectives include improving labor productivity and economic benefits through scientific management, ensuring the preservation and appreciation of state-owned assets, and maximizing shareholder benefits [8][9] - The scope of business includes manufacturing and sales of mining machinery, environmental protection equipment, mechanical and electrical equipment, software development, and various consulting services [10][11] Shares - The Company has ordinary shares and may issue other types of shares upon approval from relevant authorities [15][16] - The total number of shares issued by the Company is 1,785,399,930, with domestic shares and overseas-listed foreign shares [24][25] - The Company may issue shares to both domestic and foreign investors, with domestic shares denominated in Renminbi and foreign shares in foreign currency [18][19] Share Issuance and Capital Changes - The Company can increase its capital through various means, including issuing shares to unspecified or specific objects, allotting bonus shares, or capitalizing reserves [28][29] - The Company may reduce its registered capital in accordance with the Company Law and relevant regulations [29][30] - The Company may repurchase its shares under specific circumstances, such as reducing registered capital or merging with another company [30][31]

东方证券股份有限公司 章 程 二〇二五年五月 目 录 第一章 总则 第一条 为维护东方证券股份有限公司（以下简称"公司"）、股东和债权人 的合法权益，规范公司的组织和行为，根据《中华人民共和国公司法》（以下简 称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《证券公 司治理准则》 《上市公司章程指引》 《国务院关于股份有限公司境外募集股份及上 市的特别规定》 司召开股东大会通知期限等事项规定的批复》《到境外上市公司章程必备条款》 《关于到香港上市公司对公司章程作补充修改的意见的函》《香港联合交易所有 限公司证券上市规则》 （以下简称"《香港上市规则》"）和其他有关规定，制订本 章程。 第二条 公司系依照《公司法》《证券法》和其他有关规定，经中国证券监 督管理委员会（以下简称"中国证监会"）证监机构字（2003）184 号文和上海 市人民政府沪府体改审（2003）004 号文批准，由东方证券有限责任公司依法变 更为东方证券股份有限公司，在上海市工商行政管理局注册登记，取得营业执照 （注册号 310000000092649）。 第三条 公司于 2015 年 2 月 27 日经中国证监会批准 ...

Core Summary - The company plans to distribute a final dividend of HKD 0.318 per share for the year ending 2024, subject to shareholder approval at the upcoming annual general meeting [2] - The company will allow the issuance of new shares up to 20% of the existing share capital and repurchase up to 10% of the issued shares [2] - The annual general meeting is scheduled for June 6, 2025, in Hong Kong, with a registration deadline for shareholders on June 2, 2025 [2] Key Data and Conditions - The source of funds for the dividend will be from the share premium account, with a total of HKD 4.576 billion available for dividend payments after transferring capital reserves [2] - After the proposed dividend payment, the balance in the share premium account will be approximately HKD 3.775 billion [2] - The company has a total of 2.521 billion shares issued as of the last practicable date, with no treasury shares [2] Other Important Notes - The controlling shareholder, T.C.L. Industries (Hong Kong), holds 54.54% of the shares, which would increase to 60.60% if a full buyback occurs [2] - The company must ensure that public shareholding remains above 25% to avoid triggering mandatory offer obligations [2] - In case of adverse weather conditions, the company will announce any changes to the meeting arrangements through the Stock Exchange of Hong Kong [2]

Hong Kong Exchanges and Clearing (00388) Q1 2025 Earnings Call April 29, 2025 09:30 PM ET Speaker0 Ladies and gentlemen, the Annual General Meeting will start shortly. Today's meeting will be conducted in English. Please use the headphones to listen to the simultaneous interpretation in Cantonese, Channel two or Pudong Hua, Channel three. For those joining us through the webcast, you may select the corresponding audio channel on the top right hand corner of your screen Thank you. As mentioned in our circula ...